Cost should not be a barrier to genetic testing in patients with paragangliomas and pheochromocytomas Abstract Jennifer Thompson, Jill Dolinsky, Katherine Nathanson, Lauren Fishbein, Sarah Witherington, Shana L Merrill
NF1 mutations detected on multi-gene cancer panel testing in probands with atypical phenotypes. Abstract
Patients with multiple pathogenic mutations detected by multi-gene panel testing in a Lynch syndrome cohort Abstract Carin Espenschied, Carla Mason, Carolyn Horton, Holly Laduca, Pia Summerour, Tina Pesaran, MA, MS, CGC
Multi-gene testing for paragangliomas and pheochromocytomas: Diagnostic yield and phenotypic spectrum Carolyn Horton, Jill Dolinksy, Sarah Witherington
Diagnostic exome sequencing for patients with a family history of consanguinity: Over 40% of positive results do not follow an autosomal recessive pattern Abstract Cameron Mroske, Dima El-Khechen, Kelly Gonzalez, Layla Shahmirzadi, Zöe Powis
The clinical and psychosocial complexities of obtaining a diagnosis for rare genetic disorders: Navigating the diagnostic odyssey Elizabeth Chao, Stephanie Gandomi, Kelly Gonzalez, Amy Clugston, Jonathan Rodis, Nicole Boice
The panel results came back. Now what do I do? Cancer panel case presentations with your peers Laura Panos
Bringing ELSI issues to life: The drama of DNA Lynn Bush, Karen H. Rothenberg, Wendy Uhlmann, Barbara Biesecker, W. Andrew Faucett, Steve Keiles, Rebecca Nagy, Cate Walsh Vockley